⌘K

Login Start Free

Home/Filings/4/0001214659-16-009646

4//SEC Filing

Anthera Pharmaceuticals Inc 4

Accession 0001214659-16-009646

CIK 0001316175operating

View on SEC.gov Company Profile

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 6:17 PM ET

Size

5.2 KB

Accession

0001214659-16-009646

Insider Transaction Report

Form 4

Period: 2016-02-12

Anthera Pharmaceuticals IncANTH

Olson Charles V

CHIEF TECHNOLOGY OFFICER

Transactions

Award
Stock option (right to buy)
2016-02-12+5,626→ 5,626 total
Exercise: $2.86Exp: 2016-02-12→ Common Stock (5,626 underlying)

Footnotes (1)

[F1]This Stock Option vests immediately on February 12, 2016

Documents

1 file

4
marketforms-34475.xmlPrimary
PRIMARY DOCUMENT

Issuer

Anthera Pharmaceuticals Inc

CIK 0001316175

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001316175

Filing Metadata

Form type: 4
Filed: Feb 15, 7:00 PM ET
Accepted: Feb 16, 6:17 PM ET
Size: 5.2 KB

View on SEC.gov